Status | Study |
Recruiting |
Study Name: A Clinimetric Test of Spinal Sensors in Measuring Spinal Mobility in Axial Spondyloarthritis Condition: Ankylosing Spondylitis Axial Spondyloarthritis Date: 2017-05-16 Interventions: Device: ViMove Spinal Sensor Sensors will be used to measure spinal movement |
Not yet recruiting |
Study Name: Pharmacist CVD Intervention for Patients With Inflammatory Arthritis Condition: Inflammatory Arthritis Cardiovascular Risk Factor Rheumato Date: 2017-05-11 Interventions: Other: CV risk assessment and modification of global risk Individualized CV risk assessment using the va |
Recruiting |
Study Name: The Effects of Nanocurcumin on Serum miRNA and Th17 Cells Development Factors in Ankylosing Spondylitis Patients Condition: Ankylosing Spondylitis Date: 2017-04-28 Interventions: Drug: Nanocurcumin Nanocurcumi |
Recruiting |
Study Name: A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis Condition: Ankylosing Spondylitis Date: 2017-03-30 Interventions: Drug: filgotinib one filgotini |
Recruiting |
Study Name: Analysis of DNA Methylation in Spondyloarthritis Condition: Spondylitis, Ankylosing Axial Spondyloarthritis DNA Methyl Date: 2017-03-17 Interventions: Other: Blood sample 35 mL, 7 tubes |
Recruiting |
Study Name: The Norwegian Drug Monitoring Study Condition: Rheumatoid Arthritis Spondyloarthritis Ankylosing Spondyli Date: 2017-02-10 Interventions: Other: Therapeutic drug monitoring |
Recruiting |
Study Name: Tracking Biologics Along the Silk Road Condition: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Colitis, Ulcerative Date: 2016-12-28 |
Not yet recruiting |
Study Name: Efficacy and Safety Study of SUNPG1622 Condition: Active Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis Date: 2016-11-30 Interventions: Drug: SUNPG1622 I dose Injecti |
Recruiting |
Study Name: A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation Condition: Spondylarthritis Psoriatic Arthritis Ankylosing Spondyliti Date: 2016-11-28 |
Recruiting |
Study Name: A Multicenter Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis Condition: Ankylosing Spondylitis Date: 2016-11-10 Interventions: Other: Placebo Drug: Bimekizumab |